Second Quarter 2025 Earnings Release Presentation Aug 2025 : SGML : SGML : S2GM34 Disclaimer (…) to risks associated with its reliance on consultants and others for mineral exploration and exploitation expertise; The current COVID-19 pandemic could have a material adverse effect on Sigma's business, operations, financial condition and stock price; If Sigma is unable to ultimately generate sufficient revenues to become profitable and have positive cash flows, it could have a material adverse effect on its pr ...

Financial Performance - For the fourth quarter of fiscal year 2025, net sales reached $5082 million, a 43% increase, while adjusted EBIT was $611 million, up by 34%[12] - Fiscal year 2025 net sales amounted to $15009 million, an 11% increase, and adjusted EBIT reached $1723 million, a 12% increase[12] - Adjusted EPS for the fourth quarter decreased by 5% to 200 cents per share, while for the full fiscal year 2025, it increased by 3% to 712 cents per share[12] - The company anticipates adjusted EPS for fiscal year 2026 to be approximately 80 to 83 cents per share, representing a constant currency growth of 12% to 17% compared to fiscal year 2025[47] - The company expects free cash flow of approximately $18 to $19 billion for fiscal year 2026[47] Acquisition and Integration - The transformational acquisition of Berry Global was completed on April 30, 2025, strengthening the business and offering more complete solutions for customers[10, 5] - Integration and synergy realization are tracking in line with expectations[10] - Synergy expectations are reaffirmed, with $650 million expected by year 3 and $260 million in fiscal year 2026[19, 51] Portfolio Optimization - The company has identified a core portfolio of approximately $20 billion, focusing on consumer packaging and dispensing solutions for nutrition and health[20, 21] - Portfolio optimization actions are being explored for businesses with combined sales of approximately $25 billion, including the North America Beverage business with approximately $15 billion in sales[29, 30] Segment Performance - Global Flexible Packaging Solutions saw an 18% increase in net sales, including 16% growth from approximately $420 million in acquired sales, and an 11% increase in adjusted EBIT, including 12% growth from approximately $50 million in acquired EBIT for the fourth quarter of fiscal year 2025[35] - Global Rigid Packaging Solutions experienced a 121% increase in net sales, including 129% growth from approximately $11 billion in acquired sales, and a 173% increase in adjusted EBIT, driven by 203% growth from approximately $150 million in acquired EBIT for the fourth quarter of fiscal year 2025[40]

Financial Performance - Q2 2025 revenue was $47.4 million[21] - Nucleic Acid Production (NAP) revenue was $31.1 million, representing 66% of total revenue[37] - Biologics Safety Testing (BST) revenue was $16.3 million, accounting for 34% of total revenue[37] - The company reported a GAAP net loss of $69.8 million, which includes a $30.4 million non-cash goodwill impairment charge[27] - Adjusted EBITDA was negative $10.4 million, with an adjusted EBITDA margin of -22%[27] - Basic and Diluted EPS were both negative $0.27, while Adjusted EPS was negative $0.08[29] Balance Sheet and Cash Flow - Cash used in operations during Q2 2025 was $10.3 million[33] - The company's cash position is $270 million, with long-term gross debt of $297 million, resulting in net cash of negative $27 million[33] Strategic Initiatives - A restructuring plan is in place, targeting more than $50 million in annual cost savings[15, 39] - The company aims to return to positive adjusted EBITDA in the second half of 2026[15] - The company is targeting positive free cash flow in the second half of 2026[15]

127,127,127 Heron Therapeutics Q2 2025 Earnings Call August 8, 2025 26,68,148 84,184,72 0,125,195 75,40,108 1 Forward-looking Statements and Non-GAAP Disclosures This presentation contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. We caution investors that forward-looking statements are based on management's expectations and assumptions as of the date hereof and are subject to certain risks and uncertainties that could cause actual results to differ mat ...

Q2 FY 2025 Investor Presentation August 2025 Tripadvisor Safe Harbor Statement Forward-Looking Statements. Our presentation today, including the slides contained herein, contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are not historical facts or guarantees of future performance and are based on management's assumptions and expectations, which are inherently subject to difficult to predict uncertainties, risks and changes in c ...

Chairman, President & CEO Kent Yee Senior Vice President & CFO NASDAQ: DXPE Results for Q2 Fiscal 2025 Earnings Announcement: August 7, 2025 Presented by: David Little (Quarter Ending June 30, 2025 ) FORWARD LOOKING STATEMENTS This presentation contains forward-looking statements within the meaning of the U.S. federal securities laws that involve risks and uncertainties. Certain statements contained in this report are not purely historical, including statements regarding our expectations, beliefs, intention ...

Second Quarter 2025 Investor Presentation Information as of June 30, 2025, unless otherwise noted Safe Harbor Statement and Non-GAAP Measures Certain statements included in this presentation, including those regarding our earnings outlook, expected catastrophe losses, our investment strategies, our plans to implement additional rate actions, our plans relating to share repurchases and dividends, our efforts to enhance customer experience and expand our products and solutions to more educators, our strategie ...

Financial Performance & Strategy - APA Corporation aims to return at least 60% of free cash flow to investors through dividends and share repurchases[14] - The company initiated a long-term net debt target of $30 billion[14] - APA reduced net debt by over $850 million due to the New Mexico asset sale and progress on Egypt payments[29] - Share repurchases amounted to approximately $30 billion since year-end 2020[20] Operational Highlights - Permian Basin accounted for 75% of APA's total adjusted production[14] - Second quarter 2025 global reported production was 465078 BOE/D, with the United States contributing 289902 BOE/D and international operations producing 175176 BOE/D[28] - APA secured presidential approval for approximately 2 million acres, increasing its Egypt footprint by over 35%[29, 38] Cost Savings & Capital Efficiency - APA is accelerating controllable spend reduction targets, with realized savings of $200 million YTD 2025 and an expected YE25 run-rate of $300 million[15] - The company has reduced per-foot drilling and completion costs by over 20% since the first half of 2024 in both the Midland and Delaware Basins[33] Suriname Project - The Suriname Block 58 project is expected to generate significant free cash flow growth starting in 2028[14] - The Suriname GranMorgu project is on track for first oil in mid-2028, with an estimated recoverable resource of over 750 million barrels of oil[52, 53] Guidance - The company expects U S & U K current income tax expense of $240 million in FY25[74]

Largest Silver Producer in U.S. and Canada SECOND QUARTER 2025 Conference Call RESPONSIBLE. SAFE. INNOVATIVE. Cautionary Statements HECLA MINING COMPANY NYSE: HL SECOND QUARTER 2025 CONFERENCE CALL Cautionary Statement Regarding Forward-Looking Statements, Including 2025 Outlook This presentation and the related news release and conference call contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1 ...

Financial Performance - Net sales decreased to $4001 million in Q2 2025 from $4326 million in Q2 2024[6] - Adjusted EPS decreased to $075 per diluted share in Q2 2025 from $102 per diluted share in Q2 2024[6] - EBITDA decreased to $352 million in Q2 2025 from $394 million in Q2 2024[6] - Gross margin expanded to 170% in Q2 2025 from 168% in Q1 2025[5] Segment Performance - Supply Technologies net sales decreased to $187 million in Q2 2025 from $203 million in Q2 2024, with adjusted operating income decreasing to $167 million from $192 million[8,9] - Assembly Components net sales decreased to $95 million in Q2 2025 from $103 million in Q2 2024, with adjusted operating income decreasing to $61 million from $69 million[12,14] - Engineered Products net sales decreased to $118 million in Q2 2025 from $127 million in Q2 2024, with adjusted operating income decreasing to $64 million from $73 million[17,18] Backlog and Bookings - Engineered Products backlog increased by 19% to $172 million at June 30, 2025, from $145 million at year-end[5,19] - Record quarterly bookings of new capital equipment totaled $85 million, including a $47 million order in the Engineered Products segment[5] Outlook - The recent refinancing is expected to reduce Adjusted EPS by approximately $020 per diluted share[20] - Full-year 2025 net sales are expected to be between $1620 billion and $1650 billion[20] - Full-year 2025 Adjusted EPS is expected to be between $290 and $320 per diluted share[21] - Free cash flow is expected to improve from FY2024 and approximate $20 million to $30 million in FY2025[21]